CEP 2.0: Insights into Inspection Reports
Recommendation

20 October 2026
Copenhagen, Denmark
An ECA Course prior to the 29th APIC/CEFIC Global GMP & Regulatory API Conference
As part of the implementation of the new "CEP 2.0", the EDQM (European Directorate for the Quality of Medicines & HealthCare) has now published on its website a list of authorities and organizations that have insight into the inspection and assessment reports. With these parties there is either a confidentiality agreement or/and a memorandum of understanding.
Authorities and organizations that have access to both reports (inspection and assessment reports) include, for example, the Brazilian health authority ANVISA as well as the Saudi Arabian health authority SFDA and the WHO.
In contrast, only insights into the inspection reports are available to the following organizations and authorities:
- PIC/S, Switzerland
- MHLW, Japan
- USFDA, USA
The full list of eligible parties can be found on the EDQM website.
Furthermore, reference is again made here to the new requirements for CEP dossiers implemented on 01 June 2023. In a summary, these new requirements are listed and explained, as well as provided with further information and links.
There is also a link to the basic information on the structure and content of the CEP 2.0, as reported in a news in April.
Related GMP News
05.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
05.10.2026EDQM Updates Guidance on CEP Sister File Applications
23.09.2026IRIS Portal: EMA expands digital Procedure Management
16.09.2026EMA updates Procedural Guidance for Application Preparation
26.08.2026Centralized Marketing Authorization Procedures: Revised EMA Procedural Guidance
20.08.2026Swissmedic: eCTD v4.0


